Rachel K. Beyer
National Institutes of Health(US)Frederick National Laboratory for Cancer Research(US)
Publications by Year
Research Areas
PI3K/AKT/mTOR signaling in cancer, Protein Kinase Regulation and GTPase Signaling, CAR-T cell therapy research, Cancer Immunotherapy and Biomarkers, CRISPR and Genetic Engineering
Most-Cited Works
- → Molecular signatures of antitumor neoantigen-reactive T cells from metastatic human cancers(2022)418 cited
- → Adoptive transfer of personalized neoantigen-reactive TCR-transduced T cells in metastatic colorectal cancer: phase 2 trial interim results(2024)65 cited
- → Targeting eIF4A-Dependent Translation of KRAS Signaling Molecules(2021)35 cited
- → Replication competent retrovirus testing (RCR) in the National Gene Vector Biorepository: No evidence of RCR in 1,595 post-treatment peripheral blood samples obtained from 60 clinical trials(2022)11 cited
- → Epstein–Barr virus (EBV) antibody changes over time in a general population cohort in rural Uganda, 1992–2008(2023)6 cited
- → Estimating the Threshold Value for Change for the Six Dimensions of the Impairment Inventory of the Chedoke-McMaster Stroke Assessment(2018)1 cited
- → Supplementary Figure S3 from Targeting eIF4A-Dependent Translation of KRAS Signaling Molecules(2023)
- → Supplementary Figure S1 from Targeting eIF4A-Dependent Translation of KRAS Signaling Molecules(2023)
- → Supplementary Figure S5 from Targeting eIF4A-Dependent Translation of KRAS Signaling Molecules(2023)